SeaSpine to Present at the 2022 Ladenburg Thalmann Healthcare Conference
September 15, 2022 16:32 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Sept. 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Full Commercial Launch of the WaveForm® TA (TLIF Articulating) Interbody System
September 06, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase
August 18, 2022 16:30 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Reports 19% Revenue Growth and Record Quarterly Revenue for Second Quarter 2022 and Raises Full Year 2022 Revenue Guidance
August 02, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of Meridian™ Anterior Lumbar Interbody System Featuring Reef ™ A Interbody
August 01, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Present at the Canaccord Genuity 42nd Annual Global Growth Conference
July 26, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 26, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine to Report Second Quarter 2022 Financial Results on August 2, 2022
July 20, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 20, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Three-Year Extension and Expansion of $30 Million Credit Facility
July 19, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., July 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine® Announces Full Commercial Launch of WaveForm® C 3D-printed Interbody System
June 21, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...
SeaSpine Announces Full Commercial Launch of the WaveForm™ TO (TLIF Oblique) 3D-Printed Interbody System
June 08, 2022 16:05 ET
|
SeaSpine Holdings Corporation
CARLSBAD, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal...